High levels of pro-inflammatory cytokines, such as IL-6, CRP, cortisol [45–48], and cerebral white matter lesions [49,50] in patients with depression and frailty may adversely affect each other, leading to an increased risk of cerebrovascular disease, decreased activities of daily living, and mortality. This evidence concerns the gene CRP and depressive symptom measurement.